Pfizer and BioNTech have announced a remarkable breakthrough, after a COVID-19 vaccine proved to be 90% effective.
According to the research findings, the vaccine is effective in preventing people from contracting the corona virus.
In the 3rd Phase of Pfizer’s trial that involved 43,538 participants.
They received two doses of either the immunization or a placebo, with 90% protected from the virus within 28 days of having the jab.
Of the trial participants only 94 people developed coronavirus and no serious safety concerns were reported.
“Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,” said Pfizer chairman and chief executive Dr Albert Bourla.
“With today’s news, we are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis,” he added.
Pfizer and BioNTech’s vaccine is one of many being developed around the world in the race to end the global pandemic.
